SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-22-076943
Filing Date
2022-07-05
Accepted
2022-07-01 18:19:40
Documents
2
Group Members
AZTIQ FUND I SCSPFLOKI GP S.A R.L.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2219513d1_sc13d.htm SC 13D 67412
2 EXHIBIT 99.2 tm2219513d1_ex99-2.htm EX-99.2 7468
  Complete submission text file 0001104659-22-076943.txt   76560
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Subject) CIK: 0001898416 (see all company filings)

IRS No.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93700 | Film No.: 221062672
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5, RUE HEIENHAFF L-1736 SENNINGERBERG GRAND DUCHY N4 00000
Business Address 5, RUE HEIENHAFF L-1736 SENNINGERBERG GRAND DUCHY N4 00000 359 691 211 663
Aztiq Pharma Partners S.a r.l. (Filed by) CIK: 0001936288 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D